Doug Fairlie, Associate Professor and Head of the Cell Death and Survival Lab at the Olivia Newton-John Cancer Research Institute has nearly a decade of experience as a lab head at ONJCRI. Doug shares his insights into the institute’s evolution and its pioneering research into chemical-based treatments for melanoma and skin cancer and his team’s focus on understanding cancer’s mechanisms of treatment resistance, providing a deeper understanding of the innovative approaches being developed to improve cancer therapies.
